16: Tolerance, Autoimmunity, and Transplantation Flashcards

1
Q

What is tolerance and self-tolerance?

A

Protection imposed by the immune system to prevent the reaction of its cells and Ab’s against host components.
Central vs peripheral

Evasion, elimination, and engagement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is evasion?

A

When tolerance is favored by the partial partitioning of tissue-specific Ag’s in sensitive or immune-privileged sites, away from most immune circulation and potentially harmful inflammatory mediators.
Location and sequestration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is central tolerance?

A

Occurs in the primary lymphoid organs (PLOs):

  • Thymus for T cells
  • Bone marrow for B cells

Mechanisms that foster the destruction of self-reactive lymphocytes
(elimination) before they can mature and selection/cultivation to engage in immune inhibitory responses targeting self-Ag’s at tissue sites, protecting against autoimmunity.

Outcomes for selected cells include apoptosis, anergy, or the capacity to later inhibit selected immune responses in the periphery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is peripheral tolerance?

A
  • Not all self Ag’s are expressed in the central lymphoid organs where negative selection occur.
  • There is a threshold requirement for affinity to self Ag’s before clonal deletion is triggered, allowing some weakly self-reactive clones to survive the weeding-out process.

In secondary lymphoid organs or at tissue site where the relevant self Ag is expressed.

Ag’s that induce tolerance = tolerogens

T cell engaged by a tolerogen have several fates in addition to apoptosis:

  • Anergy (unresponsiveness)
  • Regulation (engagement leading to suppression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name some factors that promote tolerance rather than stimulation of the immune system by a given Ag

A
  • High doses of Ag
  • Long-term persistence of Ag in the host
  • Intravenous or oral introduction
  • Absence of adjuvants (compounds that enhance the immune response to Ag)
  • Low levels of costimulation.
  • Presentation of Ag by immature or unactivated APCs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are regulatory T cells, T_REGs, and how do they function to inhibit anti-self responses?

A

Types: Natural (tT_REG), peripheral (induced)
Immunophenotype:
– CD4+, CD25++, FoxP3+ (master regulator TF),CTLA-4 (coinhibitory receptor)

Inhibition through:
– Immunosuppressive microenvironment
    • Activation of IDO
– Suppressor cytokines:
    • IL-10 and TGF-beta
– Absorbs IL-2
– Targeting DC
    • Inhibitory molecules (i.e., CTLA-4)
– Effector cytoxicity

Inhibit, decommission, or kill other immune cells that respond to their cognate Ag, including T cells, B cells, and pAPCs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are regulatory B cells (B_REGs)?

A

Can, in addition to regulatory populations of macrophages (MDSCs), suppress inflammation.
Often by secreting compounds like IL-10 and by acting as immune-inhibiting APCs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is autoimmunity? Give examples on organ specific and systemic autoimmune diseases.

A

Autoimmune diseases are caused by immune-stimulatory lymphocytes or Ab’s that recognize self components, resulting in cellular lysis and/or in inflammatory response in the affected organ.

Organ specific:

  • Type 1 diabetes
  • Hashimoto’s thyroiditis
  • Myasthenia gravis

Systemic:

  • Rheumatoid arthritis
  • Multiple sclerosis
  • Systemic lupus erythematosus, (SLE/lupus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the role of genes in autoimmunity?

A

Genetic variants of one or more immune-related genes are associated with predisposition to most autoimmune disorders, most notably certain MHC (class I and II, HLA) alleles and immune-regulatory genes (e.g., AIRE and FoxP3).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which environmental factors can influence autoimmunity?

A

Diet, obesity, smoking, infection, and mucosal microflora.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What causes autoimmunity?

A

Sex/hormones, microflora,
infection (via polyclonal activation and
molecular mimicry), trauma, carcinogens
and plain old randomness.

  • V(D)J recombination (random) => different sets of Ag-specific T cell and B cell receptors.
  • Mutations in genes encoding Ag receptors, signaling molecules, costimulatory or inhibitory molecules, apoptosis regulators, or GFs.
  • Activation of B cells reactive to self-Ab’s => auto-Ab’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is molecular mimicry?

A

Some pathogens express protein epitopes resembling self-components.
When these enter the body they accidently activate self-reactive cells in a proinflammatory microenvironment, bypassing immune regulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can autoimmune diseases be treated?

A

Broad-spectrum:
Drugs that suppress systemic inflammation and/or preferentially kill certain leukocytes and their precursors, providing some relief from symptoms but with significant side effects.

Depending on cell/cytokine type:
Blocking of T/B cells, specific pathways, and subsets of cells or their products.

Blocking costimulation:
e.g., CTLA-4Ig fusion protein used in treatment of Rheumatoid arthritis (RA)

Induce tolerance to auto-antigen(s) or redirect the damaging effector response away from its target without impacting other immune processes.
Under investigation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is transplantation?

A

The act of transferring cells, tissues, or organs from one site to another, or from donor to recipient.

Can be needed because of birth defects, infection, burns, trauma, chronic disease…

Histocompatible:
Tissues that share sufficient antigenic similarity, allowing transfer without immunologic rejection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give a short description on the four types of transplants

A

Autograft:
- Self tissue from one body site to another in the same individual.

Isograft:
- Tissue transferred between genetically identical individuals, when the donor and recipient are syngeneic.

Allograft:

  • Tissue transferred between genetically different individuals within the same species.
  • Most common

Xenograft:
- Tissue transferred between different species.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are MHC alleles involved in graft rejection?

A

Loci responsible of the most vigorous graft rejection reactions are located within the MHC (HLA in humans, H2 complex in mice).

Genes in the locus are closely linked, thus inherited as a complete set from each parent (haplotype).

In outbred populations:

  • 25% chance that any two offspring will inherit identical MCH haplotypes unless the parents share a haplotype.
  • Parent-to-child grafts: the donor and recipient will have at least half their HLA alleles in common (50% match).
17
Q

Which organs are most commonly transplanted, and what does allograft survival depend on?

A

Allograft survival depends on the health of the transferred tissue, as well as the immune status of the recipient, although availability is still a substantial barrier.

Most commonly transplanted organs:

  • Kidney (75%)
  • Liver
  • Heart
  • Lung
  • Bone marrow, BM
18
Q

Mechanisms of matching donor and recipient

A

Pretransplantation tests:
- Blood group matching (blood typing)

  • MHC matching (tissue typing)
  • Cross-matching: most important level of compatibility testing.
    Positive: recipient has Ab’s against HLA proteins expressed by the donor. These are likely to lead to rapid (hyperacute) rejection.
    This status can change in an individual.
19
Q

How is the clinical course of graft rejection?

Key words: hyperacute, acute, chronic

A

Hyperacute rejection:

  • Within hours
  • Caused by damage to transplanted capillaries by preformed Ab’s recognizing foreign Ag’s, including those from the ABO blood group and HLA.

Acute rejection:

  • Weeks or months
  • Induced by the action of T cells (especially CD4+), APCs, and their cytokines after an initial sensitization to donor alloantigenes via either direct or indirect presentation to host T cells, leading to inflammation and cell death

Chronic rejection:

  • Months or years after resolution of earlier rejection responses
  • Same course of acute rejection.
  • Unknown inducers
  • More resistant to reversal by std. immunosuppression.
20
Q

Immunosuppressive therapy:

General

A

Broad-spectrum

Suppress systemic inflammation
   – Steroids – inhibiting NFkB
Inhibit proliferation
   – Mitosis
   – Crosslinking DNA
   – Inhibits purine synthesis
Significant side-effects
21
Q

Immunosuppressive therapy:

Specific

A
Monoclonal antibodies
   – Inhibit or blocking activation
   – Depletion of immune cells
       • B cells (anti-CD20)
       • T cells (anti-CD3, antiCD4)
   – More targeted => fewer side effects

Blocking costimulation
– I.e., CTLA-4Ig fusion protein

22
Q

Immune tolerance to allografts

A

Short of exposure to alloantigens in utero, tolerance can be favored when engrafted cells are placed outside the reach of the immune system or when T_REG cells against alloantigens are intentionally induced or expanded prior to transplantation.